不同的CD45+免疫格局塑造了肺瘤的微环境
Selma Dizdarević1,2, René Wiegandt2, Andreas Weigert3,4
1Institute for Lung Health (ILH), Justus-Liebig University, Giessen, Germany.
Frontiers in immunology
|February 25, 2026
概括
这项研究揭示了肺瘤中独特的CD45+免疫细胞格局,在LCL1模型中显示炎症抑制,在KrasLA2模型中显示代谢适应,为精密免疫疗法提供了洞察力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 基因组学就是基因组学.
背景情况:
- 肺瘤微环境 (TME) 显著影响肺癌的进展和转移.
- 在TME内的CD45+细胞具有复杂的作用,影响瘤行为和患者的结果.
- 了解CD45+细胞功能对于开发向性肺癌疗法至关重要.
研究的目的:
- 描述肺瘤TME内的免疫细胞组成和转录程序.
- 研究不同瘤模型 (LLC1和KrasLA2) 对CD45+免疫细胞种群的影响.
- 为潜在的精确免疫疗法确定基因型特异性免疫脆弱性.
主要方法:
- 单细胞RNA测序是在健康肺部的CD45+免疫细胞和两个不同的肺瘤模型 (LLC1和KrasLA2) 上进行的.
- 分析包括免疫细胞组成,转录程序,分化轨迹,代谢状态和细胞间通信网络.
- 进行了免疫细胞子集群 (B细胞,T细胞,NK细胞,巨细胞) 的子集群,以确定专门的变化.
主要成果:
- LLC1瘤表现出B细胞扩张和T/NK细胞减少,具有炎症和NF-κB/TNF主导的程序.
- 克拉斯LA2瘤保持了平衡的免疫组成,但显示了代谢重新连接和升高的抗原呈现特征.
- 连接体受体分析显示,LLC1瘤中的炎症网络密集,而KrasLA2瘤中的代谢调节信号.
结论:
- 独特的CD45+免疫格局,以抑制炎症 (LLC1) 或代谢适应 (KrasLA2) 为特征,塑造了肺瘤生物学.
- 这项研究提供了肺瘤免疫细胞状态的综合图谱.
- 这些发现突出了基因型特异性免疫脆弱性,这与非小细胞肺癌的精密免疫疗法有关.
相关概念视频
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K